EmVenio Announces New Community Research Site in Chicago
EmVenio Clinical Research is set to unveil a new community research site on the grounds of Saint Mary of Nazareth Hospital. This partnership with Prime Healthcare aims to enhance patient access to clinical trials, contributing to improved healthcare solutions.
Strategic Partnership for Clinical Trials
In an effort to extend their reach, EmVenio joined forces with Prime Healthcare, the operator of Saint Mary, to conduct essential clinical trials. This collaboration signifies a pivotal step in bringing innovative research opportunities to diverse patient populations.
Fostering Inclusive Research
The mission of EmVenio and Prime Healthcare is to facilitate accessible clinical research for individuals from various backgrounds and health conditions. With their new site, physicians at Saint Mary will have the resources to engage in vital research while offering patients an array of care options.
Empowering Community Physicians
Mark McKenzie, M.D., the chief medical officer of EmVenio, highlighted the importance of having a research center situated in a bustling environment like Chicago. He expressed that this location allows the research team to connect with patients from various walks of life, ensuring that the findings contribute to the health of the entire community.
Invitation for Collaboration
EmVenio is also opening its doors to contract research organizations and trial sponsors, inviting them to visit the site and meet their team. This initiative is designed to familiarize collaborators with their strategies and the therapeutic areas they cover.
Expanding Reach Across the Nation
Since the inception of the partnership between EmVenio and Prime Healthcare, several research centers have been established across key metropolitan areas including Dallas, Atlanta, Kansas City, and Detroit. This widening network reflects their commitment to enhance research access and quality.
Open House Event Announcement
On a celebratory note, EmVenio will host an open house at their new Chicago research site, welcoming all interested parties to learn more about their initiatives and impact on the community. This event promises to be an excellent opportunity for networking and collaboration.
About EmVenio Clinical Research
EmVenio Clinical Research operates globally with a dedicated team supporting clinical trials in over 90 countries. Their innovative community-based sites ensure broader access for trial participants, while simplifying the process for sponsors and contract research organizations. This approach emphasizes human connections, diversity in trial participation, and the importance of empathy at each step of the research process.
About Prime Healthcare
Prime Healthcare is recognized as a leading health system, operating numerous hospitals and outpatient facilities nationwide. With a dedicated team striving for excellence in patient care, Prime Healthcare sets itself apart with a reputation for quality and patient-first service. Their commitment to community health and outreach aligns perfectly with EmVenio’s mission.
Frequently Asked Questions
Why has EmVenio opened a new research site in Chicago?
The new site aims to increase clinical trial access for the local community, allowing patients to participate in groundbreaking research.
What is the collaboration between EmVenio and Prime Healthcare?
The partnership enhances healthcare delivery by conducting clinical trials at Prime's hospitals, improving patient outcomes through innovative research.
How can organizations collaborate with EmVenio?
Contract research organizations and trial sponsors are encouraged to visit the site, meet the staff, and explore their collaborative opportunities.
What kind of research does EmVenio focus on?
EmVenio engages in diverse therapeutic research, ensuring representation from various patient demographics to promote inclusive health solutions.
Where can I find more information about EmVenio's research efforts?
For further details, visit the EmVenio website to learn about their initiatives and clinical trial opportunities.
